 CAMBRIDGE, Mass., Feb. 09, 2022 GLOBE NEWSWIRE -- Beam Therapeutics Inc. Nasdaq: BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a fireside chat during the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, 2022 at 9:20 a.m. ET. 